This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000 Mar;25(2):108-16.

Measuring neuropsychological change in schizophrenia with novel antipsychotic medications

S E Purdon¹

Affiliations

PMID: 10740984
PMCID: PMC1408057

Review

Measuring neuropsychological change in schizophrenia with novel antipsychotic medications

S E Purdon. J Psychiatry Neurosci. 2000 Mar.

. 2000 Mar;25(2):108-16.

Author

S E Purdon¹

Affiliation

¹ Department of Psychiatry, University of Alberta, Edmonton. spurdon@gpu.srv.ualberta.ca

PMID: 10740984
PMCID: PMC1408057

No abstract available

PubMed Disclaimer

Comment in

Novel antipsychotics and the neuropsychological deficiencies of schizophrenia.
Hawkins KA. Hawkins KA. J Psychiatry Neurosci. 2000 Mar;25(2):105-7. J Psychiatry Neurosci. 2000. PMID: 10740983 Free PMC article. No abstract available.

Similar articles

Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Heinrichs RW. Heinrichs RW. Arch Gen Psychiatry. 2007 Jun;64(6):631-2. doi: 10.1001/archpsyc.64.6.631. Arch Gen Psychiatry. 2007. PMID: 17548745 No abstract available.
Another view of therapy for cognition in schizophrenia.
Carpenter WT, Gold JM. Carpenter WT, et al. Biol Psychiatry. 2002 Jun 15;51(12):969-71. doi: 10.1016/s0006-3223(02)01399-9. Biol Psychiatry. 2002. PMID: 12062880 No abstract available.
Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
Addington J, Addington D. Addington J, et al. Can J Psychiatry. 1997 Nov;42(9):983. doi: 10.1177/070674379704200919. Can J Psychiatry. 1997. PMID: 9429073 Clinical Trial. No abstract available.
Cognitive impairment as a target for pharmacological treatment in schizophrenia.
Davidson M, Keefe RS. Davidson M, et al. Schizophr Res. 1995 Sep;17(1):123-9. doi: 10.1016/0920-9964(95)00037-m. Schizophr Res. 1995. PMID: 8541245 Review. No abstract available.
Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Sharma T. Sharma T. Br J Psychiatry Suppl. 1999;(38):44-51. Br J Psychiatry Suppl. 1999. PMID: 10884899 Review. No abstract available.

See all similar articles

Cited by

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.
Csernansky JG, Schuchart EK. Csernansky JG, et al. CNS Drugs. 2002;16(7):473-84. doi: 10.2165/00023210-200216070-00004. CNS Drugs. 2002. PMID: 12056922 Review.
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
Meisenzahl EM, Scheuerecker J, Zipse M, Ufer S, Wiesmann M, Frodl T, Koutsouleris N, Zetzsche T, Schmitt G, Riedel M, Spellmann I, Dehning S, Linn J, Brückmann H, Möller HJ. Meisenzahl EM, et al. Eur Arch Psychiatry Clin Neurosci. 2006 Dec;256(8):522-31. doi: 10.1007/s00406-006-0687-x. Epub 2006 Dec 6. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 17151834
A short form of the Wisconsin Card Sorting Test.
Purdon SE, Waldie B. Purdon SE, et al. J Psychiatry Neurosci. 2001 May;26(3):253-6. J Psychiatry Neurosci. 2001. PMID: 11394197 Free PMC article. No abstract available.
Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms.
Fumagalli F, Frasca A, Racagni G, Riva MA. Fumagalli F, et al. CNS Drugs. 2009;23(7):603-14. doi: 10.2165/00023210-200923070-00005. CNS Drugs. 2009. PMID: 19552487 Review.
Atypical antipsychotic-induced metabolic disturbances in the elderly.
Guenette MD, Chintoh A, Remington G, Hahn M. Guenette MD, et al. Drugs Aging. 2014 Mar;31(3):159-84. doi: 10.1007/s40266-014-0152-x. Drugs Aging. 2014. PMID: 24477569 Review.

See all "Cited by" articles

References

1. Psychiatry Res. 1991 Jul;38(1):63-76 - PubMed
1. Br J Psychiatry. 1980 Oct;137:383-6 - PubMed
1. Schizophr Bull. 1990;16(3):477-99 - PubMed
1. Biol Psychiatry. 1996 Sep 1;40(5):434-5 - PubMed
1. Arch Gen Psychiatry. 1988 Sep;45(9):789-96 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information